Shimatani Masaaki, Hatanaka Hisashi, Kogure Hirofumi, Tsutsumi Koichiro, Kawashima Hiroki, Hanada Keiji, Matsuda Tomoki, Fujita Tomoki, Takaoka Makoto, Yano Tomonori, Yamada Atsuo, Kato Hironari, Okazaki Kazuichi, Yamamoto Hironori, Ishikawa Hideki, Sugano Kentaro
The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan.
Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi, Japan.
Am J Gastroenterol. 2016 Dec;111(12):1750-1758. doi: 10.1038/ajg.2016.420. Epub 2016 Sep 27.
To evaluate the utility and safety of a short-type double-balloon endoscope (DBE) in the treatment of biliary disease in patients with surgically altered gastrointestinal (GI) anatomy.
This study was conducted as a multicenter, single-arm, prospective trial at five tertiary academic care centers and three community-based hospitals in Japan. Consecutive patients with biliary disease with altered GI anatomy were prospectively included in this study.
A total of 311 patients underwent double-balloon endoscopic retrograde cholangiography (ERC). The success rate of reaching the target site, the primary end point, was 97.7% (95% confidence interval (CI): 95.4-99.1). The success rate of biliary cannulation and contrast injection of the targeted duct, the secondary end point, was 96.4% (95% CI: 93.6-98.2), and the therapeutic success rate was 97.9% (95% CI: 95.4-99.2). Adverse events occurred in 33 patients (10.6%, 95% CI: 7.1-14.0) and were managed conservatively in all patients with the exception of 1 in whom a perforation developed, requiring emergency surgery.
ERC using a short-type DBE resulted in an excellent therapeutic success rate and a low rate of adverse events. This treatment can be a first-line treatment for biliary disease in patients with surgically altered GI anatomy.
评估短型双气囊内镜(DBE)在治疗胃肠道(GI)解剖结构改变的患者胆道疾病中的效用和安全性。
本研究作为一项多中心、单臂、前瞻性试验,在日本的五家三级学术医疗中心和三家社区医院进行。前瞻性纳入连续的胃肠道解剖结构改变的胆道疾病患者。
共有311例患者接受了双气囊内镜逆行胆管造影(ERC)。到达目标部位(主要终点)的成功率为97.7%(95%置信区间(CI):95.4 - 99.1)。靶向胆管插管和造影剂注射(次要终点)的成功率为96.4%(95% CI:93.6 - 98.2),治疗成功率为97.9%(95% CI:95.4 - 99.2)。33例患者(10.6%,95% CI:7.1 - 14.0)发生不良事件,除1例发生穿孔需紧急手术外,所有患者均经保守治疗。
使用短型DBE进行ERC治疗成功率高,不良事件发生率低。这种治疗方法可作为胃肠道解剖结构改变的患者胆道疾病的一线治疗方法。